Gut microbiota testing and fecal immunochemical testing have also been used in the diagnosis of UC
Regulatory environment (external): Active uncertainty - FDA's April 2026 proposal to restrict 503B compounding remains open for public comment through June 29, 2026
and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders
Neurobeachin ( NBEA ) Is a Novel Gene Associated with GLP 1 Receptor Agonist Associated Weight Loss. Diabetes, Obesity and Metabolism , vol
In addition, patients should be aware of the signs and symptoms of pancreatitis, such as severe abdominal pain that radiates to the back, and seek medical attention if they experience these symptoms while taking GLP-1 receptor agonists